Connect with us

Technology

Medical Writing Market Size Indicating $ 9.09 billion by 2031, Featuring Profiles of Cactus Communications, Certara, Covance, Freyr Solutions, InClin Inc

Published

on

The report from The Insight Partners lists several stakeholders—including pharmaceutical and biotech companies, CROs, regulatory authorities, healthcare providers, and academic institutions—along with valuable insights on navigating the evolving market landscape and unlocking new opportunities successfully.

NEW YORK, Dec. 13, 2024 /PRNewswire/ — According to a new comprehensive report from The Insight Partners, global medical writing market is expected to reach US$ 9.09 billion by 2031 from US$ 3.44 billion in 2021; it is anticipated to record a CAGR of 10.2% during the forecast period. Medical writing is the creation of scientific documents that communicate medical, clinical, and healthcare information clearly and accurately. It involves preparing documents for regulatory submissions, clinical trial protocols, scientific publications, medical device documentation, and educational materials.

The medical writing market is growing owing to the expansion of the pharmaceutical, biotechnology, and medical device industries, along with an increase in clinical trials and drug development. Moreover, the growing emphasis on personalized medicine, stricter regulatory requirements, and globalization of healthcare are expected to favor market growth in the coming years.

Market leaders and key company profiles          

Cactus CommunicationsCertaraCovanceFreyr SolutionsInClin IncParexel International CorporationQuanticateSIRO Clinpharm Private LimitedSynchrogenixTrilogy Writing and Consulting GmbH

Request a Customized Copy of the Medical Writing Market Report @ https://www.theinsightpartners.com/reports/medical-writing-market/

Overview of Report Findings

Expansion of Pharmaceutical and Biotech Industries: As pharmaceutical and biotechnology sectors continue to innovate and develop drugs, therapies, and technologies, the demand for high-quality and precise documentation has surged. The growth is largely attributed to the increasing regulatory requirements, clinical trials, and research outputs that require detailed and well-structured documents such as clinical study reports, regulatory submission documents, and scientific publications. With the rapid development of mRNA vaccines, pharmaceutical companies, such as Pfizer and Moderna, have faced increased needs for medical writing expertise to ensure compliance and accuracy in regulatory filings and publications. Additionally, the increasing number of biotechnology startups has created a greater demand for outsourcing medical writing services to handle complex scientific data effectively. Thus, the expansion of the pharmaceutical and biotechnology industries drives the market.Expansion of Clinical Trials: With the increasing number of global clinical trials, especially in emerging fields such as oncology, rare diseases, and personalized medicines, there is a higher demand for medical writers to prepare essential documents, such as trial protocols, clinical study reports, investigator brochures, and patient consent forms. Additionally, the rise of decentralized and virtual clinical trials increases the complexity of documentation, requiring medical writers to adapt to new formats and regulatory standards. The growing clinical trials presents opportunities for medical writers to support sponsors and contract research organizations in ensuring regulatory compliance, accuracy, and clarity in the documentation of clinical trial data. The expansion of clinical trials provides significant opportunities in the medical writing industry as the need for precise documentation of trial processes and outcomes becomes critical.Geographical Insights: In 2021, North America led the medical writing market with a substantial revenue share, followed by Europe and APAC, respectively. Further, Asia Pacific is expected to register the highest CAGR during the forecast period.

Report Attributes

Details

Market Size in 2021

US$ 3.44 Billion

Market Size by 2031

US$ 9.09 Billion

CAGR

10.2 %

Base Year

2023

Forecast Period

 2024-2031

Historical Data

 2021-2022

Key Regional Coverage

North America (US, Canada, Mexico), Europe – [UK, Germany, France, Russia, Italy, Rest of Europe]

Asia-Pacific – [China, India, Japan, Australia, Rest of Asia-Pacific]

South and Central America [Brazil, Argentina, Rest of South and Central America]

Middle East and Africa [South Africa, Saudi Arabia, UAE and Rest of Middle East and Africa]

 

Market Segmentation

Based on type, the medical writing market is segmented into clinical writing, regulatory writing, and scientific writing. The clinical writing segment held the largest share of the market in 2021.By application, the medical writing market is categorized into medical journalism, medical education, and medico marketing. The medical education segment accounted for the largest share of the market in 2021.In terms of end users, the medical writing market is bifurcated into pharmaceutical and biotechnology companies and contract research organizations (CROs). The pharmaceutical and biotechnology companies segment led the market in 2021.The medical writing market is segmented into five major regions: North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Segments Covered –

By Type

Clinical WritingRegulatory WritingScientific Writing

By Application

Medical JournalismMedical EducationMedico Marketing

By End User

Pharmaceutical and Biotechnology CompaniesContract Research Organizations

Access PDF Sample Medical Writing Market Report (Including Graphs, Charts & Figures) – https://www.theinsightpartners.com/sample/TIPRE00008502/

Competitive Strategy and Development

Trending Topics: Regulatory writing for gene therapies and mRNA Vaccines, decentralized and virtual clinical trials, patient-centric documentation, and artificial intelligence in medical writing, among others.

Global Headlines on Medical Writing Market 

PPD Completes Evidera Acquisition, Strengthens Leadership in Real-World ResearchCognizant and Yseop Announced a Plan to Partner to Scale Medical Writing through Generative AI

Regional Analysis –

The Asia Pacific medical writing market is expected to reach US$ 983.51million in 2027 from US$ 560.59million in 2019. The market is estimated to grow with a CAGR of 7.3% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as an increased number of market players and an immense government support in the healthcare sector.The North America medical writing market is expected to reach US$ 1,266.23million in 2027 from US$ 732.95million in 2019. The market is estimated to grow with a CAGR of 7.1% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as increased requirement of medical writers due to stringent regulatory framework and robust growth in clinical trials.The Europe medical writing market is expected to reach US$ 1,114.92million in 2027 from US$ 655.84million in 2019. The market is estimated to grow with a CAGR of 6.9% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as an increased number of clinical trials and an immense growth in the medical device industry

Get Flat 30% Discount on purchase of Medical Writing Market Research Report with 10% extra customization: https://www.theinsightpartners.com/buy/TIPRE00008502/

Conclusion

The medical writing market is experiencing robust growth, driven by healthcare advancements, regulatory demands, and the expansion of clinical research. With the increasing complexity of drug development, personalized medicine, and cutting-edge therapies such as gene and cell-based treatments, the demand for highly skilled medical writers is surging. The global expansion of clinical trials, the rise of real-world evidence, and the growing focus on patient-centric documentation are further contributing to new trends in the market. Additionally, the integration of digital health technologies and artificial intelligence is reshaping the way medical writers operate, creating new opportunities for efficiency and innovation. Moreover, as the pharmaceutical and biotech industries continue to evolve, medical writing is anticipated to remain a crucial element in ensuring clarity, accuracy, and regulatory compliance in scientific communication, thereby fueling market expansion.

More Trending Latest Research Life Sciences Research Reports by The Insight Partners –

The biopharmaceuticals market is expected to grow from US$ 3,29,966.22 million in 2022 to US$ 7,00,873.94 million by 2028; it is expected to grow at a CAGR of 13.4% from 2022 to 2028

Pediatric Medical Devices market size is projected to reach US$ 54.87 billion by 2031 from US$ 32.48 billion in 2023. The market is expected to register a CAGR of 6.78% during 2023–2031

Biopharmaceutical Processing Equipment and Consumable Market Size and Forecasts 2021 – 2031

3D Printing Medical Devices Market Size and Growth 2031

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person:
Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Website – https://www.theinsightpartners.com/
Follow Us: LinkedIn | Facebook | Twitter 

Logo: https://mma.prnewswire.com/media/2520492/The_Insight_Partners_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/medical-writing-market-size-indicating–9-09-billion-by-2031–featuring-profiles-of-cactus-communications-certara-covance-freyr-solutions-inclin-inc-302331443.html

Continue Reading

Technology

Corvex to Host Third Quarter 2026 Earnings Call on Thursday, November 12, 2026

Published

on

By

ARLINGTON, Va., Nov. 3, 2026 /PRNewswire/ — Corvex, Inc. (Nasdaq: MOVE), an engineering-led AI computing platform specializing in GPU-accelerated infrastructure for AI workloads, today announced that it will report its third quarter 2026 financial results before the market open on Thursday, November 12, 2026.

Management will host a conference call and live audio webcast that day at 8:30 a.m. ET / 5:30 a.m. PT to discuss the results and provide a business update.

The call will consist of prepared remarks followed by a question-and-answer session. Investors who would like to submit a question in advance may email Corvex Investor Relations at investor-relations@corvex.ai.

The live webcast of the earnings conference call can be accessed at the Corvex Investor Relations website at investors.corvex.ai. A replay of the webcast will be available at the same website following the call. Investors can also sign up for email alerts.

About Corvex, Inc.
Corvex, Inc. (Nasdaq: MOVE) is an AI cloud computing company specializing in GPU-accelerated infrastructure for AI workloads, and a publicly traded pure-play AI compute platform. The company provides secure, scalable and cost-efficient compute resources through GPU-accelerated clusters, high-throughput storage and a layered architecture engineered for reliability, performance and efficiency at scale. Corvex’s product suite includes AI Factories and GPU Clusters, the Assured AI confidential-computing platform, as well as the Corvex Token Factory, an inference platform now publicly available. For more information, visit corvex.ai.

Investor Contact
investor-relations@corvex.ai 

Media Contact
corvex.media@stillpointglobaladvisors.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/corvex-to-host-third-quarter-2026-earnings-call-on-thursday-november-12-2026-302928409.html

SOURCE Corvex

Continue Reading

Technology

Cisco Schedules Conference Call for Q1 Fiscal Year 2027 Financial Results

Published

on

By

SAN JOSE, Calif., Nov. 3, 2026 /PRNewswire/ — Cisco (NASDAQ: CSCO) has scheduled a conference call for Thursday, Nov 12, 2026, at 1:30 PM (PT); 4:30 PM (ET) to announce its first quarter fiscal year 2027 financial results for the period ending Saturday, October 24, 2026.

Financial results will be released over PR Newswire via US National and European Financial distribution, after the close of the market on Thursday, Nov 12, 2026. Cisco’s quarterly earnings press release will be posted at https://newsroom.cisco.com.  

Date:                     
Thursday, Nov 12, 2026

Time:                     
1:30 PM (PT); 4:30 PM (ET)

To Listen via Telephone: 
888-848-6507
212-519-0847 (for International Callers)

To Listen via the Internet: 
We are pleased to offer a live and replay audio broadcast of the conference call with corresponding slides at https://investor.cisco.com.

The conference call will also be livestreamed on YouTube, LinkedIn, & X.

Replay:
A telephone playback of the Q1 FY2027 conference call is scheduled to be available beginning at 4:00 PM (PT) on Nov 12, 2026, through 11:59 PM (PT) Nov 18, 2026. The replay will be accessible by calling 800-839-2232 (International callers: 203-369-3662). The call runs 24 hours/day, including weekends. An archived version of the webcast will be available on Cisco’s Investor Relations website at https://investor.cisco.com.

About Cisco

Cisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco has securely connected the world. With its industry leading AI-powered solutions and services, Cisco enables its customers, partners and communities to unlock innovation, enhance productivity and strengthen digital resilience. With purpose at its core, Cisco remains committed to creating a more connected and inclusive future for all. Discover more on The Newsroom and follow us on X at @Cisco.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cisco-schedules-conference-call-for-q1-fiscal-year-2027-financial-results-302928403.html

SOURCE Cisco Systems, Inc.

Continue Reading

Technology

Powerfleet Sets Second Quarter Fiscal 2027 Conference Call for Monday, November 9, 2026, at 8:30 a.m. ET

Published

on

By

WOODCLIFF LAKE, N.J., Nov. 3, 2026 /PRNewswire/ — Powerfleet, Inc. (Nasdaq: AIOT) today announced that it will hold a conference call on Monday, November 9, 2026, at 8:30 a.m. Eastern time (5:30 a.m. Pacific time) to discuss results for the second quarter fiscal year 2027 ended September 30, 2026. Financial results will be issued in a press release prior to the call.

Powerfleet management will host the presentation, followed by a question-and-answer session.

Date: Monday, November 9, 2026
Time: 8:30 a.m. Eastern time (5:30 a.m. Pacific time)
Toll Free: 888-506-0062
International: 973-528-0011
Participant Access Code:  906580

The conference call will be broadcast simultaneously and available for replay here and via the investor section of the company’s website at ir.powerfleet.com.

ABOUT POWERFLEET
Powerfleet (Nasdaq: AIOT; JSE: PWR) is a global leader in the artificial intelligence of things (AIoT) software-as-a-service (SaaS) mobile asset industry. With more than 30 years of experience, Powerfleet unifies business operations through the ingestion, harmonization, and integration of data, irrespective of source, and delivers actionable insights to help companies save lives, time, and money. Powerfleet’s ethos transcends our data ecosystem and commitment to innovation; our people-centric approach empowers our customers to realize impactful and sustained business improvement. The Company is headquartered in New Jersey, United States, with offices around the globe. Explore more at www.powerfleet.com. Powerfleet has a primary listing on The Nasdaq Global Market and a secondary listing on the Main Board of the Johannesburg Stock Exchange (JSE).

Powerfleet Investor Contacts
Carolyn Capaccio and Jody Burfening
Alliance Advisors IR
AIOTIRTeam@allianceadvisors.com

Powerfleet Media Contact
Jonathan Bates
jonathan.bates@powerfleet.com 
+44 7921 242 892

View original content to download multimedia:https://www.prnewswire.com/news-releases/powerfleet-sets-second-quarter-fiscal-2027-conference-call-for-monday-november-9-2026-at-830-am-et-302928379.html

SOURCE Powerfleet

Continue Reading

Trending